These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20804896)

  • 61. Images in clinical medicine. Cutaneous lesions in diffuse large-B-cell lymphoma.
    Paredi P; Pierluigi O
    N Engl J Med; 1997 May; 336(18):1302. PubMed ID: 9113934
    [No Abstract]   [Full Text] [Related]  

  • 62. Cutaneous B-cell lymphoma treated with rituximab infusions.
    Schneider LA
    Acta Derm Venereol; 2006; 86(6):550-1. PubMed ID: 17106608
    [No Abstract]   [Full Text] [Related]  

  • 63. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma.
    Roguedas AM; Watier H; Paintaud G; de Muret A; Vaillant L; Machet L
    Br J Dermatol; 2005 Mar; 152(3):541-4. PubMed ID: 15787825
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
    Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
    Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma.
    Bachmeyer C; Orlandini V; Aractingi S
    Br J Dermatol; 2006 Jun; 154(6):1207-9. PubMed ID: 16704661
    [No Abstract]   [Full Text] [Related]  

  • 67. Splenic marginal zone lymphoma: disease features and management.
    Matutes E
    Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G; Palomera L; Varo MJ; Soria J
    Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
    [No Abstract]   [Full Text] [Related]  

  • 71. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
    Nicolay JP; Wobser M
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent advances in the management of cutaneous lymphomas.
    Belloni B; Johansen N; Glass LF; Dummer R
    Semin Oncol; 2012 Apr; 39(2):150-62. PubMed ID: 22484187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atypical shock and skin lesions revealing lymphoma.
    Fenot M; Lassalle V; Maillard H; De Ybarlucea LR; Celerier P
    Acta Derm Venereol; 2013 Sep; 93(5):592-3. PubMed ID: 23420349
    [No Abstract]   [Full Text] [Related]  

  • 75. [Malignant lymphoma of the skin: update on diagnostics and therapy of primary cutaneous B-cell lymphoma].
    Hallermann C; Niermann C; Fluck M; Fischedick AR; Schulze HJ
    Hautarzt; 2011 Dec; 62(12):947-58. PubMed ID: 22160228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [B-cell lymphoma of the nose cavity--case report].
    Rózańska-Kudelska M; Maksimowicz T; Sieśkiewicz A
    Otolaryngol Pol; 2008; 62(4):496-9. PubMed ID: 18837234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis and Management of Cutaneous B-cell Lymphoma.
    Pinter-Brown LC
    Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.
    Kheterpal M; Mehta-Shah N; Virmani P; Myskowski PL; Moskowitz A; Horwitz SM
    Curr Hematol Malig Rep; 2016 Jun; 11(3):224-33. PubMed ID: 27101016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The differential diagnosis between primary cutaneous large B-cell lymphoma and cutaneous follicular lymphoma: prognostic and therapeutic implications.
    Fernandez-Flores A; Smucler-Simonovich A; Escalante F; Manjon JA
    Am J Dermatopathol; 2011 Dec; 33(8):819-26. PubMed ID: 22042259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.